Sound and Music for Mild Cognitive Impairment

November 27, 2023 updated by: Johns Hopkins University

The Power of Sound and Music Interventions for Older Adults With Mild Cognitive Impairment

Emerging studies in humans found that 40 Hz sound induces neural gamma oscillation and enhanced cognitive function in older adults with and without Alzheimer's Disease. We will compare a 40 Hz music intervention to both 40 Hz sound and music alone in a clinical cohort of older adults with mild cognitive impairment.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21205
        • Johns Hopkins School of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 95 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Community-dwelling
  2. amnesia mild cognitive impairment
  3. Preserved function
  4. No dementia

Exclusion Criteria:

  1. known diagnosis of schizophrenia or Parkinson's disease;
  2. severe hearing impairment;
  3. presence of an acute medical or psychiatric condition which would interfere with the subject's ability to follow the study protocol realistically

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
this group will be exposed to condition A first, then B, and C
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks
Experimental: 2
this group will be exposed to condition B first, then C, and A
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks
Experimental: 3
this group will be exposed to condition C first, then A, and B
The participant will listen to the 40 Hz music playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the 40 Hz sound playlist one hour each day, 5 days a week for 4 weeks
The participant will listen to the preferred music playlist one hour each day, 5 days a week for 4 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cognitive function
Time Frame: Baseline and immediately after the 4-week intervention
Cogstate computerized assessment will be used to measure cognitive function. Higher score represents better cognitive function
Baseline and immediately after the 4-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: JUNXIN LI, PhD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

October 1, 2024

Study Registration Dates

First Submitted

September 21, 2021

First Submitted That Met QC Criteria

September 22, 2021

First Posted (Actual)

October 1, 2021

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00295386
  • R21AG078917 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on A: 40 Hz music

3
Subscribe